COPD is one of the most common respiratory diseases. Patients with COPD experience and suffer from various physical and psychological symptoms. We performed this study to identify symptom clusters and the effects on quality of life (QOL) in patients with COPD.
METHODS:
A total of 130 COPD subjects were recruited from a university hospital in South Korea. Dyspnea, fatigue, depression, anxiety, sleep disturbance, dry mouth, and physical functional status were assessed with structured questionnaires. QOL was measured with the Clinical COPD Questionnaire. Factor analysis and cluster analysis were used to identify symptom clusters based on severity of symptom experiences.
RESULTS:
Three distinct clusters were identified: a respiratory-functional cluster (symptom cluster 1), a mood cluster (symptom cluster 2), and a fatigue-sleep cluster (symptom cluster 3). Symptom cluster 1 consisted of dyspnea, physical functional status, and dry mouth; symptom cluster 2 consisted of anxiety and depression; and symptom cluster 3 consisted of sleep disturbance and fatigue. Subgroup cluster analysis showed that COPD subjects with higher-scoring symptoms in symptom clusters 1, 2, and 3 had significantly poorer QOL. The symptom clusters were significantly different depending on age, educational level, and monthly income.
CONCLUSIONS:
COPD subjects may have specific patterns of symptom clusters. The symptom clusters are related with clinical characteristics and had a negative impact on QOL. To enhance symptom management and QOL, approaches and interventions based on symptom clusters, rather than independent intervention for each symptom, may be more effective. Understanding COPD symptom clusters may help successful symptom management, which can improve QOL for COPD patients.
Centers for Disease Control and Prevention (CDC). Chronic obstructive pulmonary disease among adults—United States, 2011. MMWR Morb Mortal Wkly Rep, 2012; 61(46):938–943.
2.
VogelmeierCF, CrinerGJ, MartinezFJ, AnzuetoA, BarnesPJ, BourbeauJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: 2017 report. Respirology, 2017; 22(3):575–601.
3.
ParkSK, MeldrumCA, LarsonJL. Subgroup analysis of symptoms and their effect on functioning, exercise capacity, and physical activity in patients with severe chronic obstructive pulmonary. Heart Lung, 2013; 42(6):465–472.
4.
BorgeCR, WahlAK, MoumT. Association of breathlessness with multiple symptoms in chronic obstructive pulmonary disease. J Adv Nurs, 2010; 66(12):2688–2700.
5.
EckerbladJ, TödtK, JakobssonP, UnossonM, SkargrenE, KentssonM, TheanderK. Symptom burden in stable COPD patients with moderate or severe airflow limitation. Heart Lung, 2014; 43(4):351–357.
6.
MatteDL, PizzichiniMM, HoepersAT, DiazAP, KarlohM, DiasM, PizzichiniE. Prevalence of depression in COPD: a systematic review and meta-analysis of controlled studies. Respir Med, 2016; 117(1):154–161.
7.
KunikME, RoundyK, VeazeyC, SouchekJ, RichardsonP, WrayNP, StanleyMA. Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. Chest, 2005; 127(4):1205–1211.
8.
AntoniuSA, UngureanuD. Measuring fatigue as a symptom in COPD: from descriptors and questionnaires to the importance of the problem. Chron Respir Dis, 2015; 12(3):179–188.
9.
IguchiA, SenjyuH, HayashiY, KanadaR, IwaiS, HondaS, et al. Relationship between depression in patients with COPD and the percent of predicted FEV1, BODE index, and health-related quality of life. Respir Care, 2013; 58(2):334–339.
10.
HenochI, StrangS, LöfdahlCG, Ekberg-JanssonA. Health-related quality of life in a nationwide cohort of patients with COPD related to other characteristics. Eur Clin Respir J, 2016; 3(1):31459.
11.
BudhirahaR, ParthasarathyS, BudhirajaP, HabibMP, WendelC, QuanSF. Insomnia in patients with COPD. Sleep, 2012; 35(3):369–375.
12.
CassolatoSF, TurnbullRS. Xerostomia: clinical aspects and treatment. Gerodontology, 2003; 20(2):64–77.
13.
EkströmM, SundhJ, LarssonK. Patient reported outcome measures in chronic obstructive pulmonary disease: which to use?. Expert Rev Respir Med, 2016; 10(3):351–362.
14.
HartmanJE, BoezenHM, de GreefMH, BossenbroekL, ten HackenNH. Consequences of physical inactivity in chronic obstructive pulmonary disease. Expert Rev Respir Med, 2010; 4(6):735–745.
15.
DürrS, ZoggS, MiedingerD, StevelingEH, MaierS, LeuppiJD. Daily physical activity, functional capacity and quality of life in patients with COPD. COPD, 2014; 11(6):689–696.
16.
LenzER, PughLC, MilliganRA, GiftA, SuppeF. The middle-range theory of unpleasant symptoms: an update. ANS Adv Nurs Sci, 1997; 19(3):14–27.
17.
KimHJ, McGuireDB, TulmanL, BarsevickAM. Symptom clusters: concept analysis and clinical implications for cancer nursing. Cancer Nurs, 2005; 28(4):270–282.
FerreiraKA, KimuraM, TeixeiraMJ, MendozaTR, da NóbregaJC, GrazianiSR, TakagakiTY. Impact of cancer-related symptom synergisms on health-related quality of life and performance status. J Pain Symptom Manage, 2008; 35(6):604–616.
20.
RyuE, KimK, ChoMS, KwonIG, KimHS, FuMR. Symptom clusters and quality of life in Korean patients with hepatocellular carcinoma. Cancer Nurs, 2010; 33(1):3–10.
21.
ParkSK, LarsonJL. Symptoms cluster, healthcare use and mortality in patients with severe chronic obstructive pulmonary disease. J Clin Nurs, 2014; 23(17-18):2658–2671.
22.
ParkSK, StottsNA, DouglasMK, Donesky-CuencoD, Carrieri-KohlmanV. Symptoms and functional performance in Korean immigrants with asthma of chronic obstructive pulmonary disease. Heart Lung, 2012; 41(3):226–237.
23.
BorgCA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc, 1982; 14(5):377–381.
24.
YellenSB, CellaDF, WebsterK, BlendowskiC, KaplanE. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage, 1997; 13(2):63–74.
25.
YooS, JungYS, ParkJH, KimHJ, ChoYK, SohnCI, et al. Fatigue severity and factors associated with high fatigue levels in Korean patients with inflammatory bowel disease. Gut Liver, 2014; 8(2):148–153.
26.
OhPJ, LeeJR. Effect of cancer symptoms and fatigue on chemotherapy-related cognitive impairment and depression in people with gastrointestinal cancer. J Korean Acad Nurs, 2016; 46(3):420–430.
27.
BeckAT, WardCH, MendelsonM, MockJ, ErbaughJ. An inventory for measuring depression. Arch Gen Psychiatry, 1961; 4(6):561–571.
28.
LeeYH, SongJY. A study of the reliability and the validity of the BDI, SDS, and MMPI-D scales. Korean J Clin Psychol, 1991; 10(1):98–113.
29.
KilSY, OhWO, KooBJ, SukMH. Relationship between depression and health-related quality of life in older Korean patients with chronic obstructive pulmonary disease. J Clin Nurs, 2010; 19(9-10):1307–1314.
30.
JoSA, ParkMH, JoI, RyuSH, HanC. Usefulness of Beck Depression Inventory (BDI) in the Korean elderly population. Int J Geriatr Psychiatry, 2007; 22(3):218–223.
31.
SpielbergerCD, GorshchRL, LusheneRE. Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consultion Psychologist Press. 1970.
32.
KimJT, ShinDK. A study based on the standardization of the STAI for Korea. New Med J, 1978; 21(11):69–75.
33.
JuHO, McElmurryBJ, ParkCG, McCrearyL, KimM, KimEJ. Anxiety and uncertainty in Korean mothers of children with febrile convulsion: cross-sectional survey. J Clin Nurs, 2011; 20(9-10):1490–1497.
34.
LuoYY. Effects of written plus oral information vs. oral information alone on precolonoscopy anxiety. J Clin Nurs, 2013; 22(5-6):817–827.
35.
OhJJ, SongMS, KimSM. Development and validation of Korean Sleep Scale A. J Korean Acad Nurs, 1998; 28(3):563–572.
36.
KarnofskyDA, BurchenalJH. The clinical evaluation of chemotherapeutic agents in cancer. In McLeodCM, ed. The evaluation of chemotherapeutic agents. New York, NY: Columbia University Press. 1949; 191–205.
37.
NicolettiS, PorockD, KristjansonLJ, MedigovichK, PedlerP, SmithM. Performance status assessment in home hospice patients using a modified form of the Karnofsky Performance Status Scale. J Palliat Med, 2000; 3(3):301–311.
38.
van der MolenT, WillemseBW, SchokkerS, ten HackenNH, PostmaDS, JuniperEF. Development, validity and responsiveness of the clinical COPD questionnaire. Health Qual Life Outcomes, 2003; 1(1):13.
39.
CanavanJL, DilaverD, ClarkAL, JonesSE, NolanCM, KonSS, ManWD. Clinical COPD questionnaire in patients with chronic respiratory disease. Respirology, 2014; 19(7):1006–1012.
MiravitllesM, García-SidroP, Fernández-NistalA, BuendíaMJ, Espinosa de los MonterosMJ, MolinaJ. Course of COPD assessment test (CAT) and clinical COPD questionnaire (CCQ) scores during recovery from exacerbations of chronic obstructive pulmonary disease. Health Qual Life Outcomes, 2013; 11(1):147.
42.
KimSR, KimYO, KwonKM. Living as severe COPD patient: life of stepping on the thin ice. J Korean Acad Adult, 2010; 22(6):663–675.
43.
ValenzaMC, Valenza-PeñaG, Torres-SánchezI, González-JiménezE, Conde-ValeroA, Valenza-DemetG. Effectiveness of controlled breathing techniques on anxiety and depression in hospitalized patients with COPD: a randomized clinical trial. Respir Care, 2014; 59(2):209–215.
44.
LouP, ChenP, ZhangP, YuJ, WangY, ChenN, et al. Effects of smoking, depression, and anxiety on mortality in COPD patients: a prospective study. Respir Care, 2014; 59(1):54–61.
45.
KwekkeboomKL, CherwinCH, LeeJW, WantaB. Mind-body treatments for the pain-fatigue-sleep disturbance symptom cluster in persons with cancer. J Pain Symptom Manage, 2010; 39(1):126–138.
46.
KimSR, SoHY, ChoiE, KangJH, KimHY, ChungSJ. Influencing effect of non-motor symptom clusters on quality of life in Parkinson's disease. J Neurol Sci, 2014; 347(1-2):310–315.
47.
MiaskowskiC, CooerBA, PaulSM, DoddM, LeeK, AouixeratBE, et al. Subgroups of patients with cancer with different symptom experiences and quality-of-life outcomes: a cluster analysis. Oncol Nurs Forum, 2006; 33(5):E79–E89.
48.
KimSH, LeeR, LeeKS. Symptom clusters in patients with breast cancer. Korean J Adult Nurs, 2009; 21(6):705–717.
49.
KimEJ, ParkJH, YoonSJ, LeeSJ, ChaSI, ParkJY, et al. Relationship between dyspnea and disease severity, quality of life, and social factor in patients with chronic obstructive pulmonary disease. Tuberc Respir Dis, 2006; 60(4):397–403.
50.
FletcherCM, ElmesPC, FairbairnAS, WoodCH. The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. BMJ, 1959; 2(5147):257–266.
51.
MulloyE, McNicholasWT. Ventilation and gas exchange during sleep and exercise in severe COPD. Chest, 1996; 109(2):387–394.
52.
Akgün ŞahinZ, DayapoğluN. Effect of progressive relaxation exercises on fatigue and sleep quality in patients with chronic obstructive lung disease (COPD). Complement Ther Clin Pract, 2015; 21(4):277–281.
53.
GrossiG, JedingK, SöderströmM, OsikaW, LevanderM, PerskiA. Self-reported sleep lengths ≥9 hours among Swedish patients with stress-related exhaustion: associations with depression, quality of sleep and levels of fatigue. Nord J Psychiatry, 2014; 69(4):292–299.
